308 related articles for article (PubMed ID: 28702891)
1. Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Breast Cancer Res Treat; 2017 Nov; 166(1):145-156. PubMed ID: 28702891
[TBL] [Abstract][Full Text] [Related]
2. Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.
Lowry KP; Braunstein LZ; Economopoulos KP; Salama L; Lehman CD; Gazelle GS; Halpern EF; Giess CS; Taghian AG; Lee JM
Breast Cancer Res Treat; 2018 Aug; 171(1):209-215. PubMed ID: 29748762
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
4. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
[TBL] [Abstract][Full Text] [Related]
5. Five-year risk of interval-invasive second breast cancer.
Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
Susnik B; Schneider L; Swenson KK; Krueger J; Braatz C; Lillemoe T; Tsai M; DeFor TE; Knaack M; Rueth N
J Surg Oncol; 2018 Jul; 118(1):221-227. PubMed ID: 30196538
[TBL] [Abstract][Full Text] [Related]
7. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
[TBL] [Abstract][Full Text] [Related]
8. MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.
Nadler M; Al-Attar H; Warner E; Martel AL; Balasingham S; Zhang L; Lipton JH; Curpen B
Breast; 2017 Aug; 34():77-82. PubMed ID: 28527397
[TBL] [Abstract][Full Text] [Related]
9. Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.
Lobbes MB; Vriens IJ; van Bommel AC; Nieuwenhuijzen GA; Smidt ML; Boersma LJ; van Dalen T; Smorenburg C; Struikmans H; Siesling S; Voogd AC; Tjan-Heijnen VC
Breast Cancer Res Treat; 2017 Apr; 162(2):353-364. PubMed ID: 28132393
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.
Houssami N; Abraham LA; Kerlikowske K; Buist DS; Irwig L; Lee J; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):946-61. PubMed ID: 23513042
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
12. Outcomes Following Negative Screening MRI Results in Korean Women with a Personal History of Breast Cancer: Implications for the Next MRI Interval.
Park VY; Kim MJ; Kim GR; Yoon JH
Radiology; 2021 Aug; 300(2):303-311. PubMed ID: 34032514
[TBL] [Abstract][Full Text] [Related]
13. Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer.
Kim GR; Cho N; Kim SY; Han W; Moon WK
Radiology; 2021 Aug; 300(2):314-323. PubMed ID: 34100684
[TBL] [Abstract][Full Text] [Related]
14. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.
Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP
Breast Cancer Res Treat; 2016 Jul; 158(1):139-148. PubMed ID: 27287780
[TBL] [Abstract][Full Text] [Related]
15. First experiences in screening women at high risk for breast cancer with MR imaging.
Tilanus-Linthorst MM; Obdeijn IM; Bartels KC; de Koning HJ; Oudkerk M
Breast Cancer Res Treat; 2000 Sep; 63(1):53-60. PubMed ID: 11079159
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis.
Haas CB; Nekhlyudov L; Lee JM; Javid SH; Bush M; Johnson D; Gleason T; Kaufman C; Specht J; Stitham S; Wernli KJ
Breast Cancer Res Treat; 2020 Jun; 181(2):255-268. PubMed ID: 32303988
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performances of supplemental breast ultrasound screening in women with personal history of breast cancer.
Song SE; Cho N; Chang JM; Chu AJ; Yi A; Moon WK
Acta Radiol; 2018 May; 59(5):533-539. PubMed ID: 28786298
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
Houssami N; Abraham LA; Miglioretti DL; Sickles EA; Kerlikowske K; Buist DS; Geller BM; Muss HB; Irwig L
JAMA; 2011 Feb; 305(8):790-9. PubMed ID: 21343578
[TBL] [Abstract][Full Text] [Related]
19. Utilization of breast cancer screening with magnetic resonance imaging in community practice.
Hill DA; Haas JS; Wellman R; Hubbard RA; Lee CI; Alford-Teaster J; Wernli KJ; Henderson LM; Stout NK; Tosteson ANA; Kerlikowske K; Onega T
J Gen Intern Med; 2018 Mar; 33(3):275-283. PubMed ID: 29214373
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.
Langballe R; Mellemkjær L; Malone KE; Lynch CF; John EM; Knight JA; Bernstein L; Brooks J; Andersson M; Reiner AS; Liang X; Woods M; Concannon PJ; ; Bernstein JL
Breast Cancer Res; 2016 Jul; 18(1):65. PubMed ID: 27400983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
